Literature DB >> 14633923

Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease.

Mercè Garcia-Barceló1, Mai-Har Sham, Wing-Shan Lee, Vincent Chi-Hang Lui, Benedict Ling-Sze Chen, Kenneth Kak-Yuen Wong, Joyce Suet-Wan Wong, Paul Kwong-Hang Tam.   

Abstract

BACKGROUND: Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of ganglion cells in the nerve plexuses of the lower digestive tract. HSCR has a complex pattern of inheritance and is sometimes associated with mutations in genes of the receptor tyrosine kinase (RET) and endothelin receptor B (EDNRB) signaling pathways, which are crucial for development of the enteric nervous system.
METHODS: Using PCR amplification and direct sequencing, we screened for mutations and polymorphisms in the coding regions and intron/exon boundaries of the RET, GDNF, EDNRB, and EDN3 genes of 84 HSCR patients and 96 ethnically matched controls.
RESULTS: We identified 10 novel and 2 previously described mutations in RET, and 4 and 2 novel mutations in EDNRB and in EDN3, respectively. Potential disease-causing mutations were detected in 24% of the patients. The overall mutation rate was 41% in females and 19% in males (P = 0.06). RET mutations occurred in 19% of the patients. R114H in RET was the most prevalent mutation, representing 7% of the patients or 37% of the patients with RET mutations. To date, such a high frequency of a single mutation has never been reported in unrelated HSCR patients. Mutations in EDNRB, EDN3, and GDNF were found in four, two, and none of the patients, respectively. Two patients with mutations in genes of the EDNRB pathway also harbored a mutation in RET. Three novel and three reported polymorphisms were found in EDNRB, EDN3, and GDNF.
CONCLUSION: This study identifies additional HSCR disease-causing mutations, some peculiar to the Chinese population, and represents the first comprehensive genetic analysis of sporadic HSCR disease in Chinese.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633923     DOI: 10.1373/clinchem.2003.022061

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

Review 1.  [Molecular biology, basic research and diagnosis of Hirschsprung's disease].

Authors:  G Martucciello; O Luinetti; P Romano; U Magrini
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 2.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 3.  Familial Hirschsprung's disease: a systematic review.

Authors:  Danielle Mc Laughlin; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-07-16       Impact factor: 1.827

4.  RET and EDNRB mutation screening in patients with Hirschsprung disease: Functional studies and its implications for genetic counseling.

Authors:  Titis Widowati; Shamiram Melhem; Suryono Y Patria; Bianca M de Graaf; Richard J Sinke; Martijn Viel; Jos Dijkhuis; Ahmad H Sadewa; Rochadi Purwohardjono; Yati Soenarto; Robert Mw Hofstra; Yunia Sribudiani
Journal:  Eur J Hum Genet       Date:  2015-09-23       Impact factor: 4.246

5.  Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan.

Authors:  Trang-Tiau Wu; Tsui-Wei Tsai; Chao-Ta Chu; Zen-Fung Lee; Chuan-Mao Hung; Ching-Chyuan Su; Shuan-Yow Li; Mingli Hsieh; Chuan Li
Journal:  J Hum Genet       Date:  2005-04-15       Impact factor: 3.172

6.  Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung's disease.

Authors:  Tao Guan; Ji-Cheng Li; Min-Ju Li; Jin-Fa Tou
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

7.  Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Piyawan Chengkriwate; Sakda Patrapinyokul; Burapat Sangthong; Masahiro Fukuzawa
Journal:  J Hum Genet       Date:  2006-09-29       Impact factor: 3.172

8.  Targeted Exome Sequencing Identifies PBX1 as Involved in Monogenic Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Laurence Heidet; Vincent Morinière; Charline Henry; Lara De Tomasi; Madeline Louise Reilly; Camille Humbert; Olivier Alibeu; Cécile Fourrage; Christine Bole-Feysot; Patrick Nitschké; Frédéric Tores; Marc Bras; Marc Jeanpierre; Christine Pietrement; Dominique Gaillard; Marie Gonzales; Robert Novo; Elise Schaefer; Joëlle Roume; Jelena Martinovic; Valérie Malan; Rémi Salomon; Sophie Saunier; Corinne Antignac; Cécile Jeanpierre
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

9.  Haplotype analysis reveals a possible founder effect of RET mutation R114H for Hirschsprung's disease in the Chinese population.

Authors:  Belinda K Cornes; Clara S Tang; Thomas Y Y Leon; Kenneth J W S Hui; Man-Ting So; Xiaoping Miao; Stacey S Cherny; Pak C Sham; Paul K H Tam; Maria-Merce Garcia-Barcelo
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

Review 10.  The contribution of associated congenital anomalies in understanding Hirschsprung's disease.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.